{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:40:24Z","timestamp":1791945624274,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7659","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nature22798","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T09:55:10Z","timestamp":1497434110000},"page":"549-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":385,"title":["BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation"],"prefix":"10.1038","volume":"546","author":[{"given":"Angela","family":"Bononi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Patergnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Verbruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Signorato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Olivetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafi","family":"Kuchay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Bachir","family":"Affar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"BFnature22798_CR1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","volume":"11","author":"M Carbone","year":"2016","unstructured":"Carbone, M . et al. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. J. Thorac. Oncol. 11, 1246\u20131262 (2016)","journal-title":"J. Thorac. Oncol."},{"key":"BFnature22798_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone, M. et al. BAP1 and cancer. Nat. Rev. Cancer 13, 153\u2013159 (2013)","journal-title":"Nat. Rev. Cancer"},{"key":"BFnature22798_CR3","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","volume":"35","author":"A Napolitano","year":"2016","unstructured":"Napolitano, A. et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 35, 1996\u20132002 (2016)","journal-title":"Oncogene"},{"key":"BFnature22798_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann, F. et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis 36, 76\u201381 (2015)","journal-title":"Carcinogenesis"},{"key":"BFnature22798_CR5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa, J. R. et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022\u20131025 (2011)","journal-title":"Nat. Genet."},{"key":"BFnature22798_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","volume":"88","author":"A de la Fouchardi\u00e8re","year":"2015","unstructured":"de la Fouchardi\u00e8re, A. et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin. Genet. 88, 273\u2013277 (2015)","journal-title":"Clin. Genet."},{"key":"BFnature22798_CR7","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","volume":"7","author":"CN Njauw","year":"2012","unstructured":"Njauw, C. N. et al. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS ONE 7, e35295 (2012)","journal-title":"PLoS ONE"},{"key":"BFnature22798_CR8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao, Y. et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat. Genet. 45, 1470\u20131473 (2013)","journal-title":"Nat. Genet."},{"key":"BFnature22798_CR9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","volume":"11","author":"MN Farley","year":"2013","unstructured":"Farley, M. N. et al. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol. Cancer Res. 11, 1061\u20131071 (2013)","journal-title":"Mol. Cancer Res."},{"key":"BFnature22798_CR10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman, M. H. et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J. Med. Genet. 48, 856\u2013859 (2011)","journal-title":"J. Med. Genet."},{"key":"BFnature22798_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu, M. et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J. Thorac. Oncol. 10, 565\u2013576 (2015)","journal-title":"J. Thorac. Oncol."},{"key":"BFnature22798_CR12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413 (2010)","journal-title":"Science"},{"key":"BFnature22798_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","unstructured":"Pe\u00f1a-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751\u2013759 (2012)","journal-title":"Nat. Genet."},{"key":"BFnature22798_CR14","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1612074113","volume":"113","author":"Y Yoshikawa","year":"2016","unstructured":"Yoshikawa, Y. et al. High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma. Proc. Natl Acad. Sci. USA 113, 13432\u201313437 (2016)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature22798_CR15","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/ncomms6128","volume":"5","author":"HS Lee","year":"2014","unstructured":"Lee, H. S., Lee, S. A., Hur, S. K., Seo, J. W. & Kwon, J. Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. Nat. Commun. 5, 5128 (2014)","journal-title":"Nat. Commun."},{"key":"BFnature22798_CR16","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1158\/0008-5472.CAN-14-0221","volume":"74","author":"R Zarrizi","year":"2014","unstructured":"Zarrizi, R., Menard, J. A., Belting, M. & Massoumi, R. Deubiquitination of \u03b3-tubulin by BAP1 prevents chromosome instability in breast cancer cells. Cancer Res. 74, 6499\u20136508 (2014)","journal-title":"Cancer Res."},{"key":"BFnature22798_CR17","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1158\/0008-5472.CAN-13-3109","volume":"74","author":"IH Ismail","year":"2014","unstructured":"Ismail, I. H. et al. Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res. 74, 4282\u20134294 (2014)","journal-title":"Cancer Res."},{"key":"BFnature22798_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","volume":"111","author":"H Yu","year":"2014","unstructured":"Yu, H. et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl Acad. Sci. USA 111, 285\u2013290 (2014)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature22798_CR19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","volume":"54","author":"N Mashtalir","year":"2014","unstructured":"Mashtalir, N. et al. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol. Cell 54, 392\u2013406 (2014)","journal-title":"Mol. Cell"},{"key":"BFnature22798_CR20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","volume":"131","author":"DE Clapham","year":"2007","unstructured":"Clapham, D. E. Calcium signaling. Cell 131, 1047\u20131058 (2007)","journal-title":"Cell"},{"key":"BFnature22798_CR21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","volume":"96","author":"MJ Berridge","year":"2016","unstructured":"Berridge, M. J. The inositol trisphosphate\/calcium signaling pathway in health and disease. Physiol. Rev. 96, 1261\u20131296 (2016)","journal-title":"Physiol. Rev."},{"key":"BFnature22798_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/BSS2007c02","volume":"74","author":"K Mikoshiba","year":"2007","unstructured":"Mikoshiba, K. The IP3 receptor\/Ca2+ channel and its cellular function. Biochem. Soc. Symp. 74, 9\u201322 (2007)","journal-title":"Biochem. Soc. Symp."},{"key":"BFnature22798_CR23","doi-asserted-by":"crossref","first-page":"17404","DOI":"10.1073\/pnas.0408030101","volume":"101","author":"AE Palmer","year":"2004","unstructured":"Palmer, A. E., Jin, C., Reed, J. C. & Tsien, R. Y. Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc. Natl Acad. Sci. USA 101, 17404\u201317409 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature22798_CR24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ceca.2012.02.008","volume":"52","author":"C Giorgi","year":"2012","unstructured":"Giorgi, C. et al. Mitochondrial Ca2+ and apoptosis. Cell Calcium 52, 36\u201343 (2012)","journal-title":"Cell Calcium"},{"key":"BFnature22798_CR25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1126\/science.1189157","volume":"330","author":"C Giorgi","year":"2010","unstructured":"Giorgi, C. et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330, 1247\u20131251 (2010)","journal-title":"Science"},{"key":"BFnature22798_CR26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj3390453","volume":"339","author":"J Oberdorf","year":"1999","unstructured":"Oberdorf, J., Webster, J. M., Zhu, C. C., Luo, S. G. & Wojcikiewicz, R. J. Down-regulation of types I, II and III inositol 1,4,5-trisphosphate receptors is mediated by the ubiquitin\/proteasome pathway. Biochem. J. 339, 453\u2013461 (1999)","journal-title":"Biochem. J."},{"key":"BFnature22798_CR27","doi-asserted-by":"crossref","first-page":"40892","DOI":"10.1074\/jbc.M506623200","volume":"280","author":"CC Mendes","year":"2005","unstructured":"Mendes, C. C. et al. The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2+ signals into mitochondria. J. Biol. Chem. 280, 40892\u201340900 (2005)","journal-title":"J. Biol. Chem."},{"key":"BFnature22798_CR28","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.ajpath.2013.07.029","volume":"183","author":"F Qi","year":"2013","unstructured":"Qi, F. et al. Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-\u03b1 signaling. Am. J. Pathol. 183, 1654\u20131666 (2013)","journal-title":"Am. J. Pathol."},{"key":"BFnature22798_CR29","doi-asserted-by":"crossref","first-page":"18462","DOI":"10.1038\/srep18462","volume":"5","author":"S Bhattacharya","year":"2015","unstructured":"Bhattacharya, S., Hanpude, P. & Maiti, T. K. Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: a new insight in enzymatic inactivation. Sci. Rep. 5, 18462 (2015)","journal-title":"Sci. Rep."},{"key":"BFnature22798_CR30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner, T. et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat. Genet. 43, 1018\u20131021 (2011)","journal-title":"Nat. Genet."},{"key":"BFnature22798_CR31","first-page":"e3779","volume":"77","author":"M Vangipuram","year":"2013","unstructured":"Vangipuram, M., Ting, D., Kim, S., Diaz, R. & Sch\u00fcle, B. Skin punch biopsy explant culture for derivation of primary human fibroblasts. J. Vis. Exp. 77, e3779 (2013)","journal-title":"J. Vis. Exp."},{"key":"BFnature22798_CR32","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1073\/pnas.170207097","volume":"97","author":"M Bocchetta","year":"2000","unstructured":"Bocchetta, M. et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc. Natl Acad. Sci. USA 97, 10214\u201310219 (2000)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature22798_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","volume":"59","author":"HI Pass","year":"1995","unstructured":"Pass, H. I. et al. Characteristics of nine newly derived mesothelioma cell lines. Ann. Thorac. Surg. 59, 835\u2013844 (1995)","journal-title":"Ann. Thorac. Surg."},{"key":"BFnature22798_CR34","first-page":"1530","volume":"42","author":"S Tsuchiya","year":"1982","unstructured":"Tsuchiya, S. et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42, 1530\u20131536 (1982)","journal-title":"Cancer Res."},{"key":"BFnature22798_CR35","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey, A. et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541\u20131546 (2012)","journal-title":"Science"},{"key":"BFnature22798_CR36","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/nprot.2013.127","volume":"8","author":"M Bonora","year":"2013","unstructured":"Bonora, M. et al. Subcellular calcium measurements in mammalian cells using jellyfish photoprotein aequorin-based probes. Nat. Protocols 8, 2105\u20132118 (2013)","journal-title":"Nat. Protocols"},{"key":"BFnature22798_CR37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nprot.2006.172","volume":"1","author":"AE Palmer","year":"2006","unstructured":"Palmer, A. E. & Tsien, R. Y. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat. Protocols 1, 1057\u20131065 (2006)","journal-title":"Nat. Protocols"},{"key":"BFnature22798_CR38","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/nprot.2009.151","volume":"4","author":"MR Wieckowski","year":"2009","unstructured":"Wieckowski, M. R., Giorgi, C., Lebiedzinska, M., Duszynski, J. & Pinton, P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protocols 4, 1582\u20131590 (2009)","journal-title":"Nat. Protocols"},{"key":"BFnature22798_CR39","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/nprot.2007.365","volume":"2","author":"JW Slot","year":"2007","unstructured":"Slot, J. W. & Geuze, H. J. Cryosectioning and immunolabeling. Nat. Protocols 2, 2480\u20132491 (2007)","journal-title":"Nat. Protocols"},{"key":"BFnature22798_CR40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ncb2731","volume":"15","author":"S Kuchay","year":"2013","unstructured":"Kuchay, S. et al. FBXL2- and PTPL1-mediated degradation of p110-free p85\u03b2 regulatory subunit controls the PI(3)K signalling cascade. Nat. Cell Biol. 15, 472\u2013480 (2013)","journal-title":"Nat. Cell Biol."},{"key":"BFnature22798_CR41","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.1006542107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang, H. et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc. Natl Acad. Sci. USA 107, 12611\u201312616 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature22798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature22798","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature22798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature22798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:02:34Z","timestamp":1684418554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature22798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":41,"journal-issue":{"issue":"7659","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnature22798"],"URL":"https:\/\/doi.org\/10.1038\/nature22798","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"3 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C. has pending patent applications on BAP1. M.C. provides consultation for mesothelioma diagnosis. The authors have no other potential competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}